PDF herunterladen
Synlett 2011(9): 1277-1280  
DOI: 10.1055/s-0030-1260535
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Hydrazone-Promoted Sonogashira Coupling Reaction with Aryl Bromides at Low Palladium Loadings

Takashi Mino*, Saori Suzuki, Kiminori Hirai, Masami Sakamoto, Tsutomu Fujita
Department of Applied Chemistry and Biotechnology, Graduate School of Engineering, Chiba University, 1-33, Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
Fax: +81(43)2903401; e-Mail: tmino@faculty.chiba-u.jp;
Weitere Informationen

Publikationsverlauf

Received 10 February 2011
Publikationsdatum:
20. April 2011 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The Sonogashira coupling reaction of aryl bromides with a variety of terminal alkynes in DMSO at 125 ˚C gave internal aryl­ated alkynes using low-loaded Pd(acac)2 with hydrazone as a ligand and CuI as the co-catalyst in good yields.

Key words

palladium - catalysis - Sonogashira coupling reaction - hydrazone

    References and Notes

  • For recent reviews, see the following:
  • 1a Torborg C. Beller M. Adv. Synth. Catal.  2009,  351:  3027 
    Google Scholar
  • 1b Pal M. Synlett  2009,  2896 
    Google Scholar
  • 1c Chinchilla R. Nájera C. Chem. Rev.  2007,  107:  874 
    Google Scholar
  • 1d Doucet H. Hierso J.-C. Angew. Chem. Int. Ed.  2007,  46:  834 
    Google Scholar
  • 2a Shang H. Hua R. Zheng Q. Zhang J. Liang X. Zhu Q. Appl. Organomet. Chem.  2010,  24:  473 
    Google Scholar
  • 2b Hierso J.-C. Beaupérin M. Meunier P. Eur. J. Org. Chem.  2007,  3767 
    Google Scholar
  • 2c Hierso J.-C. Fihri A. Amardeil R. Meunier P. Doucet H. Santelli M. Tetrahedron  2005,  61:  9759 
    Google Scholar
  • 3a Churruca F. SanMartin R. Tellitu I. Domínguez E. Synlett  2005,  3116 
    Google Scholar
  • 3b Sajiki H. Zhang G. Kitamura Y. Maegawa T. Hirota K. Synlett  2005,  619 
    Google Scholar
  • 4 Buchmeiser MR. Schareina T. Kempe R. Wurst K.
    J. Organomet. Chem.  2001,  634:  39 
    CrossrefGoogle Scholar
  • 5 Consorti CS. Flores FR. Rominger F. Dupont J. Adv. Synth. Catal.  2006,  348:  133 
    CrossrefGoogle Scholar
  • 6a Mino T. Shirae Y. Sakamoto M. Fujita T. J. Org. Chem.  2005,  70:  2191 
    Google Scholar
  • 6b Mino T. Shirae Y. Sasai Y. Sakamoto M. Fujita T. J. Org. Chem.  2006,  71:  6834 
    Google Scholar
  • 6c Mino T. Shirae Y. Saito T. Sakamoto M. Fujita T. J. Org. Chem.  2006,  71:  9499 
    Google Scholar
  • 6d Mino T. Kajiwara K. Shirae Y. Sakamoto M. Fujita T. Synlett  2008,  2711 
    Google Scholar
  • 6e Mino T. Shindo H. Kaneda T. Koizumi T. Kasashima Y. Sakamoto M. Fujita T. Tetrahedron Lett.  2009,  50:  5358 
    Google Scholar
  • 6f Mino T. Koizumi T. Shibuya M. Hirai K. Sakamoto M. Fujita T. Heterocycles  2011,  83:  163 
    Google Scholar
  • 8 Liang B. Dai M. Chen J. Yang Z. J. Org. Chem.  2005,  70:  391 
    CrossrefPubMedGoogle Scholar
  • 9 Chen H.-J. Lin Z.-Y. Li M.-Y. Lian R.-J. Xue Q.-W. Chung J.-L. Chen S.-C. Chen Y.-J. Tetrahedron  2010,  66:  7755 
    CrossrefGoogle Scholar
  • 10 Yang F. Wu Y. Eur. J. Org. Chem.  2007,  3476 
    Google Scholar
  • 11 Huang H. Liu H. Jiang H. Chen K. J. Org. Chem.  2008,  73:  6037 
    CrossrefGoogle Scholar
  • 12 Ling Y. Xie Y.-X. Li J.-H. J. Org. Chem.  2006,  71:  379 
    CrossrefGoogle Scholar
  • 13 Harjani JR. Abraham TJ. Gomez AT. Garcia MT. Singer RD. Scammells PJ. Green Chem.  2010,  12:  650 
    CrossrefGoogle Scholar
  • 14 Basu B. Das P. Das P. Mandal B. Banerjee D. Almqvist F. Synthesis  2009,  1137 
    Artikel in Thieme ConnectGoogle Scholar
7

General Procedure for the Sonogashira Reaction of Aryl Bromides with Alkynes
To a mixture of aryl bromide (1.0 mmol), K3PO4 (1.0 mmol), alkyne (1.2 mmol), CuI (0.005 mmol), and ligand 1a (0.005 or 0.006 mmol) in DMSO (4.0 mL) was added Pd(acac)2 (0.001, 0.01, or 0.1 mol%) in DMSO (0.01 M, 1.0, 10.0, or 100.0 µL) at r.t. under an atmosphere of argon. The mixture was stirred at 125 ˚C for 24 h. The resulting mixture was diluted with EtOAc and H2O. The organic layer was washed with brine, dried over MgSO4, and concentrated under reduced pressure. The residue was purified by silica gel chromatography.
Compound 3a 6c (entry 1, Table  [²] ): 89% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.37 (s, 3 H), 7.14 (d, J = 7.9 Hz, 2 H), 7.30-7.36 (m, 3 H), 7.42 (d, J = 8.1 Hz, 2 H), 7.51-7.54 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 88.7, 89.5, 120.2, 123.5, 128.0, 128.3, 129.1, 131.48, 131.52, 138.4. MS (EI): m/z (%) = 192 (100) [M+]. Compound 3b 8 (entry 2, Table  [²] ): 94% as a brown solid. ¹H NMR (300 MHz, CDCl3): δ = 7.35-7.41 (m, 3 H), 7.51-7.66 (m, 6 H). ¹³C NMR (75 MHz, CDCl3): δ = 87.7, 93.8, 111.4, 118.5, 122.2, 128.2, 128,5, 129.1, 131.8, 132.03, 132.04. MS (EI): m/z (%) = 203 (100) [M+].
Compound 3c 6c (entry 3, Table  [²] ): 88% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 7.36-7.38 (m, 3 H), 7.52-7.65 (m, 6 H). ¹³C NMR (75 MHz, CDCl3): δ = 87.9, 91.7, 122.5, 123.9 (q, J = 272.0 Hz), 125.3 (q, J = 3.7 Hz), 127.1 (d, J = 1.5 Hz), 128.4, 128.8, 129.9 (q, J = 32.6 Hz), 131.7, 131.8. MS (EI): m/z (%) = 246 (100) [M+].
Compound 3d 6c (entry 4, Table  [²] ): 81% as a yellow solid ¹H NMR (300 MHz, CDCl3): δ = 2.62 (s, 3 H), 7.36-7.38 (m, 3 H), 7.54-7.63 (m, 4 H), 7.93-7.96 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 26.6, 88.6, 92.7, 122.6, 128.2, 128.3, 128.4, 128.8, 131.68, 131.72, 136.1, 197.3. MS (EI): m/z (%) = 220 (100) [M+].
Compound 3e 6c (entry 6, Table  [²] ): 83% as a brown solid. ¹H NMR (300 MHz, CDCl3): δ = 3.83 (s, 3 H), 6.86-6.89 (m, 2 H), 7.31-7.36 (m, 3 H), 7.46-7.53 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 55.3, 88.0, 89.3, 114.0, 115.3, 123.6, 127.9, 128.3, 131.4, 133.0, 159.6. MS (EI): m/z (%) = 208 (100) [M+].
Compound 3f 6c (entry 7, Table  [²] ): 67% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 7.25-7.39 (m, 6 H), 7.51-7.55 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 89.3, 123.2, 128.2, 128.3, 131.6. MS (EI): m/z (%) = 178 (100) [M+].
Compound 3g 9 (entry 8, Table  [²] ): 91% as a yellow liquid. ¹H NMR (300 MHz, CDCl3): δ = 2.35 (s, 3 H), 7.15 (d, J = 7.6 Hz, 1 H), 7.21-7.26 (m, 1 H), 7.32-7.36 (m, 5 H), 7.51-7.54 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 20.7, 88.3, 93.3, 123.0, 123.5, 125.6, 128.2, 128.28, 128.33, 129.4, 131.5, 131.8, 140.2. MS (EI): m/z (%) = 192 (100) [M+].
Compound 3h ¹0 (entry 10, Table  [²] ): 82% as a colorless liquid. ¹H NMR (300 MHz, CDCl3): δ = 7.36-7.38 (m, 3 H), 7.45-7.60 (m, 4 H), 7.70 (d, J = 7.7 Hz, 1 H), 7.80 (s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 87.8, 90.9, 122.6, 123.7 (q, J = 272.5 Hz), 124.2, 124.7 (q, J = 3.8 Hz), 128.4 (q, J = 4.0 Hz), 128.4, 128.7, 128.9, 131.0 (q, J = 32.7 Hz), 131.7, 134.6 (d, J = 1.0 Hz). MS (EI): m/z (%) = 246 (100) [M+].
Compound 3i ¹¹ (entry 11, Table  [²] ): 60% as a brown liquid. ¹H NMR (300 MHz, CDCl3): δ = 3.82 (s, 3 H), 6.89 (ddd, J = 1.0, 2.6, 8.3 Hz, 1 H), 7.06-7.07 (m, 1 H), 7.12-7.15 (m, 1 H), 7.25-7.28 (m, 1 H), 7.33-7.36 (m 3 H), 7.52-7.55 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 55.3, 89.2, 89.3, 114.9, 116.3, 123.2, 124.16, 124.24, 128.28, 128.33, 129.4, 131.6, 159.3. MS (EI): m/z (%) = 208 (100) [M+].
Compound 3j ¹² (entry 12, Table  [²] ): 66% as a colorless liquid. ¹H NMR (300 MHz, CDCl3): δ = 2.30 (s, 6 H), 6.97 (s, 1 H), 7.17 (s, 2 H), 7.32-7.37 (m, 3 H), 7.50-7.53 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.1, 88.7, 89.7, 122.8, 123.4, 128.1, 128.3, 129.3, 130.2, 131.6, 137.9. MS (EI): m/z (%): =206 (100) [M+].
Compound 3k 6c (entry 13, Table  [²] ): 42% as a colorless liquid. ¹H NMR (300 MHz, CDCl3): δ = 2.51 (s, 3 H), 7.14-7.24 (m, 3 H), 7.33-7.39 (m, 3 H), 7.49-7.56 (m, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 20.7, 88.3, 93.3, 123.0, 123.5, 125.6, 128.2, 128.28, 128.32, 129.4, 131.5, 131.8, 140.2.
MS (EI): m/z (%) = 192 (100) [M+].
Compound 3l 9 (entry 14, Table  [²] ): 34% as a yellow liquid. ¹H NMR (300 MHz, CDCl3): δ = 3.91 (s, 3 H), 6.90 (d, J = 8.1 Hz, 1 H), 6.95 (dd, J = 1.0, 7.5 Hz, 1 H), 7.24-7.37 (m, 4 H), 7.49-7.52 (m, 1 H), 7.55-7.58 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 55.8, 85.6, 93.4, 110.7, 112.4, 120.5, 123.5, 128.0, 128.2, 129.7, 131.6, 133.6, 159.9. MS: m/z (%) = 220 (100) [M+].
Compound 3m 6c (entry 15, Table  [²] ): 84% as a yellow liquid. ¹H NMR (300 MHz, CDCl3): δ = 7.34-7.67 (m, 8 H), 7.77 (dd, J = 1.0, 7.1 Hz, 1 H), 7.83-7.88 (m, 2 H), 8.45 (d, J = 8.2 Hz, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 87.9, 94.7, 121.3, 123.8, 125.7, 126.6, 126.8, 127.2, 128.7, 128.79, 128.84, 129.2, 130.8, 132.1, 133.6, 133.7. MS: m/z (%) = 228 (100) [M+].
Compound 3n ¹³ (entry 16, Table  [²] ): 34% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 7.20 (dd, J = 1.1, 5.0 Hz, 1 H), 7.24-7.37 (m, 4 H), 7.49-7.55 (m, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 84.5, 88.8, 122.3, 123.2, 125.3, 128.2, 128.3, 128.6, 129.9, 131.5. MS: m/z (%) = 184 (100) [M+].
Compound 3o 9 (entry 17, Table  [²] ): 82% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3 H), 3.82 (s, 3 H), 6.87 (d, J = 8.8 Hz, 2 H), 7.14 (d, J = 7.9 Hz, 2 H), 7.39-7.47 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 55.3, 88.2, 88.6, 113.9, 115.6, 120.5, 129.1, 131.3, 133.0, 138.0, 159.5. MS: m/z (%) = 222 (100) [M+].
Compound 3p 6c (entry 19, Table  [²] ): 59% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.36 (s, 6 H), 7.14 (d, J = 7.9 Hz, 4 H), 7.41 (d, J = 8.1 Hz, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 88.8, 120.3, 129.1, 131.4, 138.2. MS (EI): m/z (%) = 206 (100) [M+].
Compound 3q 6c (entry 20, Table  [²] ): 56% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.37 (s, 3 H), 6.99-7.07 (m, 2 H), 7.15 (d, J = 7.9 Hz, 2 H), 7.41 (d, J = 8.2 Hz, 2 H), 7.46-7.53 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 87.6, 89.2 (d, J = 1.3 Hz), 115.5 (d, J = 22.0 Hz), 119.6 (d, J = 3.5 Hz), 120.0, 129.1, 131.4, 133.4 (d, J = 8.3 Hz), 138.5, 162.4 (d, J = 249.2 Hz). MS (EI): m/z (%) = 210 (100) [M+].
Compound 3r ¹4 (entry 21, Table  [²] ): 69% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.34 (s, 3 H), 2.36 (s, 3 H), 7.12-7.25 (m, 4 H), 7.31-7.43 (m, 4 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.2, 21.5, 88.9, 89.2, 120.2, 123.2, 128.2, 128.6, 129.0, 129.1, 131.5, 132.1, 138.0, 138.3. MS (EI): m/z (%) = 206 (100) [M+].
Compound 3s 6c (entry 22, Table  [²] ): 73% as a white solid. ¹H NMR (300 MHz, CDCl3): δ = 2.37 (s, 3 H), 7.06-7.17 (m, 4 H), 7.25-7.33 (m, 1 H), 7.44-7.54 (m, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 21.5, 82.0, 94.6 (d, J = 3.3 Hz), 112.1 (d, J = 15.9 Hz), 115.5 (d, J = 20.9 Hz), 119.8, 123.9 (d, J = 3.9 Hz), 129.1, 129.7 (d, J = 8.0 Hz), 131.6, 133.4 (d, J = 1.0 Hz), 138.8, 162.6 (d, J = 251.4 Hz). MS (EI): m/z (%) = 210 (100) [M+].